Centrum Wealth Management

"Credit growth and consumption and capex– the Cs – will lead to the fourth C which is corporate profitability. We are on a different tangent altogether. Whether the Indian market also gets…

“Sun Pharma is not on my buy list. Companies like Syngene or MNC pharma companies or Dr Lal Path Lab comes to mind immediately, if one wants to get exposure to the healthcare space after…

In pharma, money right now is going towards MNC pharma companies or diagnostic companies or for that matter even hospital companies, says Devang Mehta, Head-Equity Advisory, Centrum Wealth…